Blood-Brain barrier breakdown in the aging human hippocampus

Neuron

Volumn 85, Issue 2, 2015, Pages 296-302

  Montagne, Axel ^a   Barnes, Samuel R ^b   Sweeney, Melanie D ^a   Halliday, Matthew R ^a   Sagare, Abhay P ^a   Zhao, Zhen ^a   Toga, Arthur W ^a   Jacobs, Russell E ^b   Liu, Collin Y ^a   Amezcua, Lilyana ^a   Harrington, Michael G ^c   Chui, Helena C ^a   Law, Meng ^a   Zlokovic, Berislav V ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

^c HUNTINGTON MEDICAL RESEARCH INSTITUTES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; ALBUMINOID; SERUM ALBUMIN;

ADULT; AGED; AGING; ALZHEIMER DISEASE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN MAPPING; BRAIN PERICYTE; CEREBROSPINAL FLUID ANALYSIS; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DENTATE GYRUS; FEMALE; HIPPOCAMPAL CA1 REGION; HIPPOCAMPUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMBRANE PERMEABILITY; MILD COGNITIVE IMPAIRMENT; MOUSE; MULTIPLE SCLEROSIS; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; BRAIN; BRAIN CORTEX; CASE CONTROL STUDY; CAUDATE NUCLEUS; CEREBROSPINAL FLUID; HIPPOCAMPAL CA3 REGION; METABOLISM; MIDDLE AGED; NEOSTRIATUM; PERICYTE; PERMEABILITY; THALAMUS; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; AGING; ALBUMINS; BLOOD-BRAIN BARRIER; BRAIN; CA1 REGION, HIPPOCAMPAL; CA3 REGION, HIPPOCAMPAL; CASE-CONTROL STUDIES; CAUDATE NUCLEUS; CEREBRAL CORTEX; DENTATE GYRUS; FEMALE; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEOSTRIATUM; PERICYTES; PERMEABILITY; SERUM ALBUMIN; THALAMUS; YOUNG ADULT;

EID: 84921326695     PISSN: 08966273     EISSN: 10974199     Source Type: Journal    
DOI: 10.1016/j.neuron.2014.12.032     Document Type: Article

References (47)

1. Aksoy D., Bammer R., Mlynash M., Venkatasubramanian C., Eyngorn I., Snider R.W., Gupta S.N., Narayana R., Fischbein N., Wijman C.A. Magnetic resonance imaging profile of blood-brain barrier injury in patients with acute intracerebral hemorrhage. J.Am. Heart Assoc. 2013, 2:e000161.
2. Apostolova L.G., Hwang K.S., Andrawis J.P., Green A.E., Babakchanian S., Morra J.H., Cummings J.L., Toga A.W., Trojanowski J.Q., Shaw L.M., et al. 3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects. Neurobiol. Aging 2010, 31:1284-1303. Alzheimer's Disease Neuroimaging Initiative.
3. Armulik A., Genové G., Mäe M., Nisancioglu M.H., Wallgard E., Niaudet C., He L., Norlin J., Lindblom P., Strittmatter K., et al. Pericytes regulate the blood-brain barrier. Nature 2010, 468:557-561.
4. Baloyannis S.J., Baloyannis I.S. The vascular factor in Alzheimer's disease: a study in Golgi technique and electron microscopy. J.Neurol. Sci. 2012, 322:117-121.
5. Bell R.D., Deane R., Chow N., Long X., Sagare A., Singh I., Streb J.W., Guo H., Rubio A., Van Nostrand W., et al. SRF and myocardin regulate LRP-mediated amyloid-β clearance in brain vascular cells. Nat. Cell Biol. 2009, 11:143-153.
6. Bell R.D., Winkler E.A., Sagare A.P., Singh I., LaRue B., Deane R., Zlokovic B.V. Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging. Neuron 2010, 68:409-427.
7. Bell R.D., Winkler E.A., Singh I., Sagare A.P., Deane R., Wu Z., Holtzman D.M., Betsholtz C., Armulik A., Sallstrom J., et al. Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature 2012, 485:512-516.
8. Blennow K., Wallin A., Fredman P., Karlsson I., Gottfries C.G., Svennerholm L. Blood-brain barrier disturbance in patients with Alzheimer's disease is related to vascular factors. Acta Neurol. Scand. 1990, 81:323-326.
9. Bowman G.L., Kaye J.A., Quinn J.F. Dyslipidemia and blood-brain barrier integrity in Alzheimer's disease. Curr. Gerontol. Geriatr. Res. 2012, 2012:184042.
10. Braak H., Braak E., Bohl J. Staging of Alzheimer-related cortical destruction. Eur. Neurol. 1993, 33:403-408.
11. Cullen K.M., Kócsi Z., Stone J. Pericapillary haem-rich deposits: evidence for microhaemorrhages in aging human cerebral cortex. J.Cereb. Blood Flow Metab. 2005, 25:1656-1667.
12. Daneman R., Zhou L., Kebede A.A., Barres B.A. Pericytes are required for blood-brain barrier integrity during embryogenesis. Nature 2010, 468:562-566.
13. Deane R., Du Yan S., Submamaryan R.K., LaRue B., Jovanovic S., Hogg E., Welch D., Manness L., Lin C., Yu J., et al. RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain. Nat. Med. 2003, 9:907-913.
14. Farkas E., Luiten P.G. Cerebral microvascular pathology in aging and Alzheimer's disease. Prog. Neurobiol. 2001, 64:575-611.
15. Fiala M., Liu Q.N., Sayre J., Pop V., Brahmandam V., Graves M.C., Vinters H.V. Cyclooxygenase-2-positive macrophages infiltrate the Alzheimer's disease brain and damage the blood-brain barrier. Eur. J. Clin. Invest. 2002, 32:360-371.
16. Goos J.D., Kester M.I., Barkhof F., Klein M., Blankenstein M.A., Scheltens P., van der Flier W.M. Patients with Alzheimer disease with multiple microbleeds: relation with cerebrospinal fluid biomarkers and cognition. Stroke 2009, 40:3455-3460.
17. Halliday M.R., Pomara N., Sagare A.P., Mack W.J., Frangione B., Zlokovic B.V. Relationship between cyclophilin a levels and matrix metalloproteinase 9 activity in cerebrospinal fluid of cognitively normal apolipoprotein e4 carriers and blood-brain barrier breakdown. JAMA Neurol. 2013, 70:1198-1200.
18. Hultman K., Strickland S., Norris E.H. The APOE ε4/ε4 genotype potentiates vascular fibrin(ogen) deposition in amyloid-laden vessels in the brains of Alzheimer's disease patients. J.Cereb. Blood Flow Metab. 2013, 33:1251-1258.
19. Iadecola C. Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat. Rev. Neurosci. 2004, 5:347-360.
20. Iadecola C. The pathobiology of vascular dementia. Neuron 2013, 80:844-866.
21. LaFerla F.M. Preclinical success against Alzheimer's disease with an old drug. N.Engl. J. Med. 2012, 367:570-572.
22. Larsson H.B., Courivaud F., Rostrup E., Hansen A.E. Measurement of brain perfusion, blood volume, and blood-brain barrier permeability, using dynamic contrast-enhanced T(1)-weighted MRI at 3 tesla. Magn. Reson. Med. 2009, 62:1270-1281.
23. Morris J.C., Weintraub S., Chui H.C., Cummings J., Decarli C., Ferris S., Foster N.L., Galasko D., Graff-Radford N., Peskind E.R., et al. The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers. Alzheimer Dis. Assoc. Disord. 2006, 20:210-216.
24. Mu Y., Gage F.H. Adult hippocampal neurogenesis and its role inAlzheimer's disease. Mol. Neurodegener. 2011, 6:85.
25. Park L., Zhou J., Zhou P., Pistick R., El Jamal S., Younkin L., Pierce J., Arreguin A., Anrather J., Younkin S.G., et al. Innate immunity receptor CD36 promotes cerebral amyloid angiopathy. Proc. Natl. Acad. Sci. USA 2013, 110:3089-3094.
26. Patlak C.S., Blasberg R.G. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations. J.Cereb. Blood Flow Metab. 1985, 5:584-590.
27. Polman C.H., Reingold S.C., Banwell B., Clanet M., Cohen J.A., Filippi M., Fujihara K., Havrdova E., Hutchinson M., Kappos L., et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann. Neurol. 2011, 69:292-302.
28. Raven E.P., Lu P.H., Tishler T.A., Heydari P., Bartzokis G. Increased iron levels and decreased tissue integrity in hippocampus of Alzheimer's disease detected invivo with magnetic resonance imaging. J.Alzheimers Dis. 2013, 37:127-136.
29. Ryu J.K., McLarnon J.G. A leaky blood-brain barrier, fibrinogen infiltration and microglial reactivity in inflamed Alzheimer's disease brain. J.Cell. Mol. Med. 2009, 13(9A):2911-2925.
30. Sagare A.P., Bell R.D., Zhao Z., Ma Q., Winkler E.A., Ramanathan A., Zlokovic B.V. Pericyte loss influences Alzheimer-like neurodegeneration in mice. Nat. Commun. 2013, 4:2932.
31. Salloway S., Gur T., Berzin T., Tavares R., Zipser B., Correia S., Hovanesian V., Fallon J., Kuo-Leblanc V., Glass D., et al. Effect ofAPOE genotype on microvascular basement membrane in Alzheimer's disease. J.Neurol. Sci. 2002, 203-204:183-187.
32. Sengillo J.D., Winkler E.A., Walker C.T., Sullivan J.S., Johnson M., Zlokovic B.V. Deficiency in mural vascular cells coincides with blood-brain barrier disruption in Alzheimer's disease. Brain Pathol. 2013, 23:303-310.
33. Squire L.R. Memory and the hippocampus: a synthesis from findings with rats, monkeys, and humans. Psychol. Rev. 1992, 99:195-231.
34. Taheri S., Gasparovic C., Huisa B.N., Adair J.C., Edmonds E., Prestopnik J., Grossetete M., Shah N.J., Wills J., Qualls C., Rosenberg G.A. Blood-brain barrier permeability abnormalities in vascular cognitive impairment. Stroke 2011, 42:2158-2163.
35. Taheri S., Gasparovic C., Shah N.J., Rosenberg G.A. Quantitative measurement of blood-brain barrier permeability in human using dynamic contrast-enhanced MRI with fast T1 mapping. Magn. Reson. Med. 2011, 65:1036-1042.
36. Taheri S., Rosenberg G.A., Ford C. Quantification of blood-to-brain transfer rate in multiple sclerosis. Mult. Scler. Relat. Disord. 2013, 2:124-132.
37. Weintraub S., Salmon D., Mercaldo N., Ferris S., Graff-Radford N.R., Chui H., Cummings J., DeCarli C., Foster N.L., Galasko D., et al. The Alzheimer's disease centers' uniform data set (UDS): The neuropsychological test battery. Alzheimer Dis. Assoc. Disord. 2009, 23:91-101.
38. Whitwell J.L., Wiste H.J., Weigand S.D., Rocca W.A., Knopman D.S., Roberts R.O., Boeve B.F., Petersen R.C., Jack C.R. Comparison of imaging biomarkers in the Alzheimer disease neuroimaging initiative and the Mayo Clinic Study of Aging. Arch. Neurol. 2012, 69:614-622. Alzheimer Disease Neuroimaging Initiative.
39. Winkler E.A., Bell R.D., Zlokovic B.V. Central nervous system pericytes in health and disease. Nat. Neurosci. 2011, 14:1398-1405.
40. Winkler E.A., Sengillo J.D., Bell R.D., Wang J., Zlokovic B.V. Blood-spinal cord barrier pericyte reductions contribute to increased capillary permeability. J.Cereb. Blood Flow Metab. 2012, 32:1841-1852.
41. Winkler E.A., Sengillo J.D., Sagare A.P., Zhao Z., Ma Q., Zuniga E., Wang Y., Zhong Z., Sullivan J.S., Griffin J.H., et al. Blood-spinal cord barrier disruption contributes to early motor-neuron degeneration in ALS-model mice. Proc. Natl. Acad. Sci. USA 2014, 111:E1035-E1042.
42. Yoshita M., Fletcher E., Harvey D., Ortega M., Martinez O., Mungas D.M., Reed B.R., DeCarli C.S. Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD. Neurology 2006, 67:2192-2198.
43. Zhu D., Wang Y., Singh I., Bell R.D., Deane R., Zhong Z., Sagare A., Winkler E.A., Zlokovic B.V. Protein S controls hypoxic/ischemic blood-brain barrier disruption through the TAM receptor Tyro3 and sphingosine 1-phosphate receptor. Blood 2010, 115:4963-4972.
44. Zipser B.D., Johanson C.E., Gonzalez L., Berzin T.M., Tavares R., Hulette C.M., Vitek M.P., Hovanesian V., Stopa E.G. Microvascular injury and blood-brain barrier leakage in Alzheimer's disease. Neurobiol. Aging 2007, 28:977-986.
45. Zlokovic B.V. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 2008, 57:178-201.
46. Zlokovic B.V. Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat. Rev. Neurosci. 2011, 12:723-738.
47. Zonneveld H.I., Goos J.D., Wattjes M.P., Prins N.D., Scheltens P., van der Flier W.M., Kuijer J.P., Muller M., Barkhof F. Prevalence of cortical superficial siderosis in a memory clinic population. Neurology 2014, 82:698-704.